Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects

NCT03770039 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Subjects

Interventions

DRUG: Oral PF-06700841 containing 14C microtracer
DRUG: Oral unlabeled PF-06700841
DRUG: IV 14C-labeled PF-06700841

Sponsor

Pfizer